femoston-conti 0.5mg/2.5mg film-coated tablets
mylan ire healthcare limited - estradiol; dydrogesterone - film-coated tablet - 0.5/2.5 milligram(s) - progestogens and estrogens, fixed combinations; dydrogesterone and estrogen
femoston-conti 1 mg/5 mg film-coated tablets
mylan ire healthcare limited - estradiol; dydrogesterone - film-coated tablet - 1mg/5mg milligram(s) - progestogens and estrogens, fixed combinations; dydrogesterone and estrogen
femoston-conti 1 mg/5 mg film-coated tablets
pco manufacturing ltd. - dydrogesterone; estradiol - film-coated tablet - 1 mg/5 milligram(s) - progestogens and estrogens, fixed combinations; dydrogesterone and estrogen
femoston-conti 0.5 mg/2.5 mg film-coated tablets
pco manufacturing ltd. - estradiol; dydrogesterone - film-coated tablet - progestogens and estrogens, fixed combinations; dydrogesterone and estrogen
femoston-conti 1 mg/5 mg film-coated tablets
imed healthcare ltd. - estradiol; dydrogesterone - film-coated tablet - progestogens and estrogens, fixed combinations; dydrogesterone and estrogen
femoston 110 tablet
abbott laboratories (singapore ) private limited - dydrogesterone, micronized (in grey tablet); estradiol hemihydrate 1.03 mg eqv estradiol (micronised) (in grey tablet); estradiol hemihydrate 1.03 mg eqv estradiol (micronised) (in white tablet) - tablet, film coated - 10 mg - dydrogesterone, micronized (in grey tablet) 10 mg; estradiol hemihydrate 1.03 mg eqv estradiol (micronised) (in grey tablet) 1 mg; estradiol hemihydrate 1.03 mg eqv estradiol (micronised) (in white tablet) 1 mg
femoston conti 0.5mg/2.5mg film-coated tablets
bgp products ltd - dydrogesterone 2.5 mg, estradiol 0.5 mg - film-coated tablet
femoston-conti 1mg/5mg milligram film coated tablet
bgp products ltd - estradiol, dydrogesterone - film coated tablet - 1mg/5mg milligram - progestogens and estrogens, fixed combinations - : genito urinary system and sex hormones, progestogens and oestrogens, fixed combinations - hormone replacement therapy (hrt) for oestrogen deficiency symptoms in postmenopausal women at least 12 months since last menses. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis
femoston-conti 0.5/2.5 milligram film coated tablet
bgp products ltd - estradiol, dydrogesterone - film coated tablet - 0.5/2.5 milligram - progestogens and estrogens, fixed combinations
femoston 1/5 conti tablets film-coated
abbott biologicals b.v. - estradiol (estradiol hemihydrate), dydrogesterone - tablets film-coated - 1mg+ 5mg